Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Indian pharma must step up r&d, compliance focus for global play

180 views

Published on

Indian pharma must step up r&d, compliance focus for global play

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Indian pharma must step up r&d, compliance focus for global play

  1. 1. Indian Pharma Must Step Up R&D, Compliance Focus for Global Play Cos' profitability to come under pressure from higher cost of compliance, developing new products Brought to you by The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-
  2. 2. Contd.. What takes one from A to B doesn't necessarily help in moving from B to C. That's the situation with the Indian pharma industry as it grows to tap the opportunities in the global healthcare market. The industry has reaped the low-hanging fruits of low-cost generics, making Indian pharma companies one of the most profitable ones globally. But, the future is likely to be tough with profitability coming under pressure. The cost of compliance is slated to increase in the years ahead. US FDA and other drug regulators, especially from developed markets, have stepped up scrutiny and are penalising companies not complying with their good manufacturing practices. Companies have little option but to increase compliance especially to avoid severe punitive actions like import bans and revocation of drug approvals. Brought to you by The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-
  3. 3. Contd.. Given the regulatory clamps faced by Indian pharma companies from foreign drug regulators, the Indian drug regulator is considering bridging the gap between the compliance standards of India and those recommended by World Health Organization. This means increased cost on compliance at home as well as in offshore markets. To remain competitive and relevant in the global drug industry, Indian firms will have to increase investment towards research and development from the current average of 6-7% of their revenues. The cost of filing new drug appli cations with the US FDA has already increased since the Generic Drug User Fee Act was enforced in the US. The firms also have to contend with growing pricing pressures in domestic and overseas markets. Globally, there is a tendency among governments to pull down healthcare cost. Thus, price control pressures are likely to prevail or even intensify in some markets. Brought to you by The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-
  4. 4. Contd.. Consolidation is rampant in the global pharma landscape with Indian companies also buying assets to scale up inorganically . But, valuations are not cheap for healthy assets, and distressed assets come with regulatory issues. To cut dependency on a single market, companies are diversifying geographic footprint. This increases their risk profile as they are subject to the vagaries of the different markets they enter. For instance, companies faced pricing pressure in Germany and currency volatility was a problem in Russia and CIS countries. The overall risk profile of the pharma sector has changed in the recent years.Make no mistake. It's no longer a classic defensive sector. Brought to you by The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-
  5. 5. This platform has been started by Parveen Kumar Chadha with the vision that nobody should suffer the way he has suffered because of lack and improper healthcare facilities in India. We need lots of funds manpower etc. to make this vision a reality please contact us. Join us as a member for a noble cause. Brought to you by The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-
  6. 6. Our views have increased the mark of the 2,10,000  Thank you viewers  Looking forward for franchise, collaboration, partners. Brought to you by The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-
  7. 7. 011-25464531, 011-41425180, 011-66217387 +91-9818308353,+91-9818569476 othermotherindia@gmail.com www.other-mother.in https://www.facebook.com/pages/Other-Mother-Nursing-Crusade/224235031114989?ref=hl http://www.linkedin.com/profile/view?id=326103341&trk=nav_responsive_tab_profile https://twitter.com/othermotherindi https://cparveen.wix.com/other-mother A WORLDWIDE MISSITION Contact Us:- JOIN US www.parveenchadha.com The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:- We are also available on Justdial New Delhi. Brought to you by

×